Northwestern Medicine scientists received a five-year, $3.9 million grant from the National Institutes of Health to determine the optimal drug doses for treating pregnant women with depression.
Northwestern Medicine scientist Jeffrey Savas, PhD, and colleagues identified a receptor that sorts proteins in synapses, a finding that may augment future treatments for multiple neurological diseases and disorders.
Northwestern Medicine scientists investigated the mechanism behind a mutation in a calcium ion channel that leads to an immunodeficiency syndrome.
Northwestern Medicine scientists, inspired by treatments used by traditional healers in Nigeria, have synthesized four new chemical compounds that may lead to therapies for psychiatric disorders.
Male baldness clinical trials did not adequately report sexual dysfunction, which may persist long-term, according to a Northwestern Medicine meta-analysis of published reports of clinical trials of the drug finasteride.
A new Northwestern Medicine study published in the New England Journal of Medicine shows the drug Eylea is superior to other options for improving the eyesight of persons with poor vision due to diabetic macular edema, a major cause of diabetes-related vision loss.
A $5 million grant from the National Institutes of Health will support research to determine the functional and structural consequences of genetic mutations associated with a dangerous heart condition.
Scientists from Northwestern Medicine have discovered a key function for the CRAC channel, which transports calcium into cells.
Milan Mrksich, PhD, professor in the Department of Cell and Molecular Biology, has created a tool and a startup company to test biological reactions quickly and cheaply.